In contrast to NDRG1, NDRG2 acts as a tumor suppressor, inhibiting proliferation and cell survival via regulations of MAPK/STAT3, cyclin-D1, β-catenin, NF-κB, E-cadherin, and other signaling pathways [23,81,84,85]. The gene discussed is NDRG2; the disease is neoplasm.